# Clinical Trial of the Use of Ketamine in Treatment Resistant Depression

> **NCT02610712** · PHASE4 · UNKNOWN · sponsor: **National Institute of Neurology and Neurosurgery, Mexico** · enrollment: 20 (estimated)

## Conditions studied

- Depressive Disorder, Treatment-Resistant

## Interventions

- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT02610712
- **Lead sponsor:** National Institute of Neurology and Neurosurgery, Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2017-12
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2016-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02610712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02610712, "Clinical Trial of the Use of Ketamine in Treatment Resistant Depression". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT02610712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*